Prevalence and Clinical Characteristics of Patients With Jackhammer Esophagus and Symptoms of Gastroesophageal Reflux Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03347903

Recruitment Status : Completed

First Posted : November 20, 2017

Last Update Posted : November 21, 2017

Sponsor:

Information provided by (Responsible Party):

Dr. Ivan Kristo, Medical University of Vienna

Study Description

Brief Summary:

Gastroesophageal reflux disease (GERD) is involved in the development of esophageal motility disorders like Jackhammer esophagus (JE), a novel hypercontractile condition that was associated with progression to achalasia and limited outcomes following surgical anti-reflux therapy.

This trial was designed to assess the prevalence and characteristics of JE in patients with typical symptoms of GERD and responsiveness to PPI therapy.

Condition or disease
Esophageal Motility Disorders

Detailed Description:

Jackhammer esophagus is a novel hypercontractile esophageal disorder. The investigators assess the prevalence and clinical characteristics of patients diagnosed with this disorder out of a collective of patients that are referred with symptoms of gastroesphageal reflux disease and respond to PPI. This is an observational trial.

Study Design

Layout table for study information

Study Type :	Observational
Actual Enrollment :	37 participants
Observational Model:	Cohort
Time Perspective:	Prospective
Official Title:	Prevalence and Clinical Characteristics of Patients With Jackhammer Esophagus and Symptoms of Gastroesophageal Reflux Disease
Actual Study Start Date :	January 1, 2014
Actual Primary Completion Date :	May 30, 2017
Actual Study Completion Date :	May 30, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: GERD

Genetic and Rare Diseases Information Center resources: Jackhammer Esophagus

U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Primary Outcome Measures :

Prevalence of Jackhammer esophagus in patients referred with symptoms of gastroesophageal reflux disease [ Time Frame: January 2014- May 2017 ]
All patients that are referred to our center with symptoms of gastroesophageal reflux disease routinely undergo high-resolution manometry. We assess how many patients are diagnosed with Jackhammer esophagus

Secondary Outcome Measures :

Symptom perception [ Time Frame: January 2014- May 2017 ]
We assess which symptoms are perceived by the patients diagnosed with Jackhammer esophagus. All data are observed during an interview at the high-resolution manometry
Prevalence of gastroesophageal reflux disease in patients with Jackhammer esophagus [ Time Frame: Januar 2014- May 2017 ]
All patients that are referred to our center are evaluated for gastroesophageal reflux disease. We assess the prevalence of gastroesophageal reflux disease in patients with Jackhammer esophagus diagnosed by ambulatory pH monitoring.

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information

Ages Eligible for Study:	18 Years to 75 Years (Adult, Older Adult)
Sexes Eligible for Study:	All
Sampling Method:	Probability Sample

Study Population

All patients that are referred to our center undergo esophageal high-resolution manometry and ambulatory pH monitoring for screening of gastroesophageal reflux disease and motility disorders. We assess the data that are prospectively obtained. Patients do not have to undergo any interventions.

Criteria

Inclusion Criteria:

Patients with symptoms of gastroesophageal reflux disease and diagnosis of Jackhammer esophagus

Exclusion Criteria:

patients not willing to participate data or undergo screening for gastroesophageal reflux disease

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03347903

Sponsors and Collaborators

Medical University of Vienna

Investigators

Layout table for investigator information

Principal Investigator:	Sebastian Schoppmann, MD	Vice Chair of Department of General Surgery

More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Kristo I, Schwameis K, Maschke S, Kainz A, Rieder E, Paireder M, Jomrich G, Schoppmann SF. Phenotypes of Jackhammer esophagus in patients with typical symptoms of gastroesophageal reflux disease responsive to proton pump inhibitors. Sci Rep. 2018 Jul 2;8(1):9949. doi: 10.1038/s41598-018-27756-9.

Layout table for additonal information

Responsible Party:	Dr. Ivan Kristo, Dr. med. univ., Medical University of Vienna
ClinicalTrials.gov Identifier:	NCT03347903
Other Study ID Numbers:	1164/2017
First Posted:	November 20, 2017 Key Record Dates
Last Update Posted:	November 21, 2017
Last Verified:	November 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD:	Undecided

Layout table for additional information

Studies a U.S. FDA-regulated Drug Product:	No
Studies a U.S. FDA-regulated Device Product:	No

Keywords provided by Dr. Ivan Kristo, Medical University of Vienna:


esophagus motility

Additional relevant MeSH terms:

Layout table for MeSH terms

Gastroesophageal Reflux Esophageal Motility Disorders Esophageal Spasm, Diffuse Deglutition Disorders	Esophageal Diseases Gastrointestinal Diseases Digestive System Diseases

To Top